A randomized trial was performed to determine relative efficacy and toxicity of two first-line combination chemotherapy regimens in women with metastatic breast cancer: CFP (cyclophosphamide, 5-fluorouracil, prednisone) and C M F P (cyclophosphamide, 5-fluorouracil, methotrexate, prednisone). Both r
β¦ LIBER β¦
Perceptions and needs of women with metastatic breast cancer: A focus on clinical trials
β Scribed by Nahleh, Zeina A.; Lin, Nancy U.; Wolff, Antonio C.; Cardoso, Fatima
- Book ID
- 122611458
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 123 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0960-9776
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Randomized clinical trial of CFP versus
β
Robert F. Marschke JR.; James N. Ingle; Daniel J. Schaid; James E. Krook; James
π
Article
π
1989
π
John Wiley and Sons
π
English
β 644 KB
0203 Evaluating the needs of women livin
β
M. Mayer; A. Hunis; R. Oratz; C. Glennon; P. Spicer; E. Caplan; L. Fallowfield
π
Article
π
2009
π
Elsevier Science
π
English
β 49 KB
Women with newly diagnosed breast cancer
β
BjΓΈrg Th Landmark; Ann BΓΈhler; Kari Loberg; Astrid K Wahl
π
Article
π
2008
π
John Wiley and Sons
π
English
β 87 KB
Mapping the quality of life and unmet ne
β
S. ARANDA; P. SCHOFIELD; L. WEIH; P. YATES; D. MILNE; R. FAULKNER; N. VOUDOURIS
π
Article
π
2005
π
John Wiley and Sons
π
English
β 98 KB
Vaginal Dryness and Beyond: The Sexual H
Vaginal Dryness and Beyond: The Sexual Health Needs of Women Diagnosed With Metastatic Breast Cancer
β
McClelland, Sara I.; Holland, Kathryn J.; Griggs, Jennifer J.
π
Article
π
2014
π
Taylor and Francis Group
π
English
β 178 KB
Prognostic factors in elderly women with
β
Madhav V. Dhodapkar; James N. Ingle; Stephen S. Cha; James A. Mailliard; H. Sam
π
Article
π
1996
π
John Wiley and Sons
π
English
β 593 KB
## BACKGROUND. Information regarding prognostic factors and survival in elderly women with metastatic breast cancer treated with tamoxifen is limited. METHODS. The data from 4 prospective clinical trials were analyzed, including information on 396 postmenopausal women with advanced breast cancer w